Abstract
Animal models have been used to study cellular processes related to human immunodeficiency virus-1 (HIV-1)-associated neurocognitive disorders (HAND). The HIV-1 transgenic (Tg) rat expresses HIV viral genes except the gag-pol replication genes and exhibits neuropathological features similar to HIV patients receiving combined antiretroviral therapy (cART). Using this rat, alterations in dopaminergic function have been demonstrated; however, the data for neuroinflammation and glial reactivity is conflicting. Differences in behavior, tyrosine hydroxylase (TH) immunoreactivity, neuroinflammation, and glia reactivity were assessed in HIV-1 Tg male rats. At 6 and 12 weeks of age, rotarod performance was diminished, motor activity was not altered, and active avoidance latency performance and memory were diminished in HIV-1 Tg rats. TH+ immunoreactivity in the substantia nigra (SN) was decreased at 8 months but not at 2–5 months. At 5 months, astrocyte and microglia morphology was not altered in the cortex, hippocampus, or SN. In the striatum, astrocytes were unaltered, microglia displayed slightly thickened proximal processes, mRNA levels for Iba1 and Cd11b were elevated, and interleukin (Il)1α,Cxcr3, and cell adhesion molecule, Icam, decreased. In the hippocampus, mRNA levels for Tnfa and Cd11b were slightly elevated. No changes were observed in the cortex or SN. The data support an age-related effect of HIV proteins upon the nigrostriatal dopaminergic system and suggest an early response of microglia in the terminal synaptic region with little evidence of an associated neuroinflammatory response across brain regions.
Similar content being viewed by others
References
Atluri VS, Kanthikeel SP, Reddy PV, Yndart A, Nair MP (2013) Human synaptic plasticity gene expression profile and dendritic spine density changes in HIV-infected human CNS cells: role in HIV-associated neurocognitive disorders (HAND). PLoS One 8:e61399. https://doi.org/10.1371/journal.pone.0061399
Avdoshina V, Fields JA, Castellano P, Dedoni S, Palchik G, Trejo M, Adame A, Rockenstein E, Eugenin E, Masliah E, Mocchetti I (2016) The HIV Protein gp120 Alters Mitochondrial Dynamics in Neurons. Neurotox Res 29 (4):583-593
Avdoshina V, Caragher SP, Wenzel ED, Taraballi F, Moccchetti I, Harry GJ (2017) The viral protein gp120 decreases the acetylation of neuronal tubulin: potential mechanism of neurotoxicity. J Neurochem 141:606–613
Bachis A, Wenzel E, Boelk A, Becker J, Mocchetti I (2016) The neurotrophin receptor p75 mediates gp120-induced loss of synaptic spines in aging mice. Neurobiol Aging 46:160–168
Bansal AK, Mactutus CF, Nath A, Maragos W, Hauser KF, Booze RM (2000) Neurotoxicity of HIV-1 proteins gp120 and Tat in the rat striatum. Brain Res 879:42–49
Blanchard HC, Taha AY, Rapoport SI, Yuan Z-X (2015) Low-dose aspirin (acetylsalicylate) prevents increases in brain PGE2, 15-epi-lipoxin A4 and 8-isoprostane concentrations in 9 month-old HIV-1 transgenic rats, a model for HIV-1 associated neurocognitive disorders. Prostaglandins Leukot Essent Fat Acids 96:25–30
Berger JR, Kumar M, Kumar A, Fernandez JB, Levin B (1994) Cerebrospinal fluid dopamine in HIV-1 infection. AIDS 8:67-71
Bertrand SJ, Mactutus CF, Harrod SB, Moran LM, Booze RM (2018) HIV-1 proteins dysregulate motivational processes and dopamine circuitry. Sci Rep 8:7869
Boban J, Kozic D, Turkulov V, Ostojic J, Semnic R, Lendak D, Brkic S (2017) HIV-associated neurodegeneration and neuroimmunity: multivoxel MR spectroscopy study in drug-naïve and treated patients. Eur Radiol 27:4218–4236
Casas R, Muthusamy S, Wakim PG, Sinharay S, Lentz MR, Reid WC, Hammoud DA (2017) MR brain volumetric measurements are predictive of neurobehavioral impairment in the HIV-1 transgenic rat. NeuroImge Clin 17:659–666
Chan P, Hellmuth J, Spudich S, Valcour V (2016) Cognitive impairment and persistent CNS injury in treated CNS. Curr HIV/AIDS Rep 13:209–217. https://doi.org/10.1007/s11904-016-0319-7
Chen MF, Gill AJ, Kolson DL (2014) Neuropathogenesis of HIV-associated neurocognitive disorders: roles for immune activation, HIV blipping and viral tropism. Curr Opin HIV AIDS 9:559-564
Chivero ET, Guo M-L, Periyasamy P, Liao K, Callen SE, Buch S (2017) HIV-1 Tat primes and activates microglial NLRP3 inflammasome-mediated neuroinflammation. J Neurosci 37:3599–3609
Cho Y-E, Lee M-H, Song B-J (2017) Neuronal cell death and degeneration through increased nitroxidative stress and tau phosphorylation in HIV-1 transgenic rats. PLoS One 12(1):e0169945
Clifford KM, Samboju V, Cobigo Y, Milanini B, Marx GA, Hellmuth JM, Rosen HJ, Kramer JH, Allen IE, Valcour VG (2017) Progressive brain atrophy despite persistent viral suppression in HIV over age 60. J Acquir Immune Defic Syndr 76:289–297
DeVaughn S, Müller-Oehring EM, Markey B, Brontë-Stewart HM, Schulte T (2015) Aging with HIV-1 infection: motor functions, cognition, and attention – a comparison with Parkinson’s Disease. Neuropsychol Rev 25:424–438
Gannon P, Khan MZ, Kolson DL (2011) Current understanding of HIV-associated neurocognitive disorders pathogenesis. Curr Opin Neurol 24:275–283. https://doi.org/10.1097/WCO.0b013e32834695fb
Gaskill PJ, Carvallo L, Eugenin EA, Berman JW (2012) Characterization and function of the human macrophage dopaminergic system: implications for CNS disease and drug abuse. J Neuroinflammation 9:203. https://doi.org/10.1186/1742-2094-9-203
Gaskill PJ, Calderon TM, Coley JS, Berman JW (2013) Drug induced increases in CNS dopamine alter monocyte, macrophage and T cell functions: implications for HAND. J NeuroImmune Pharmacol 8:621–642
Gaskill PJ, Yano HH, Kalpana GV, Javitch JA, Berman JW (2014) Dopamine receptor activation increases HIV entry into primary human macrophages. PLoS One 9:e108232
Gaskill PJ, Miller DR, Gamble-George J, Yano H, Khoshbouei H (2017) HIV, Tat and dopamine transmission. Neurobiol Dis 105:51–73
Gelman BB (2015) Neuropathology of HAND with suppressive antiretroviral therapy: encephalitis and neurodegeneration reconsidered. Curr HIV/AIDS Rep 12:272–279
Gelman BB, Spencer JA, Holzer CE III, Soukup VM (2006) Abnormal striatal dopaminergic synapses in national NeuroAIDS tissue consortium subjects with HIV encephalitis. J NeuroImmune Pharmacol 1:410–420
Ginsberg SD, Alldred MJ, Sunnam SM, Schiroli C, Lee SH, Morgello S, Fischer T (2018) Expression profiling suggests microglial impairment in human immunodeficiency virus neuropathogenesis. Ann Neurol 83:206–417
Gundersen HJG, Jensen EBV, Kieu K, Nielsen J (1999) The efficiency of systematic sampling in stereology - reconsidered. J Micros 193(3):199-211
Guo M, Bryant J, Sultana S, Jones O, Royal W III, (2012) Effects of vitamin A deficiency and opioids on parvalbumin+ interneurons in the hippocampus of the HIV-1 transgenic rat. Curr HIV Res 10(5):463-468
Harry GJ, Hooth MJ, Vallant M, Behl M, Travlos GS, Howard JL, Price CJ, McBride S, Mervis R, Mouton PR (2014) Developmental neurotoxicity of 3,3′,4,4′-tetrachloroazobenzene with thyroxine deficit: sensitivity of glia and dentate granule neurons in the absence of behavioral changes. Toxics 3:496–532
Heaton RK, Clifford DB, Franklin DR Jr, Woods SP, Ake C, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Rivera-Mindt M, Vigil OR, Taylor MJ, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I, For the CHARTER Group (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 75:2087–2096
Heppner FL, Roth K, Nitsch R, Hailer NP (1998) Vitamin E induces ramification and downregulation of adhesion molecules in cultured microglial cells. Glia 22:180–188
Hong S, Banks WA (2015) Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications. Brain Behav Immun 45:1–12
Hu S, Sheng WS, Lokensgard JR, Peterson PK, Rock RB (2009) Preferential sensitivity of human dopaminergic neurons to gp120-induced oxidative damage. J Neurovirol 15:401–410
Itoh K, Mehraein P, Weis S (2000) Neuronal damage of the substantia nigra in HIV-1 infected brains. Acta Neuropathol 99:376–384
Javadi-Paydar M, Roscoe RF Jr, Denton AR, Mactutus CF, Booze RM (2017) HIV-1 and cocaine disrupt dopamine reuptake and medium spiny neurons in female rat striatum. PLoS One 12(11):e0188404. https://doi.org/10.1371/journal.pone.0188404
June HL, Yang ARST, Bryant JL, Jones O, Royal W (2009) Vitamin A deficiency and behavioral and motor deficits in the HIV-1 transgenic rat. J Neurovirol 15:380–389
Kanaan NM, Kordower JH, Collier TJ (2008) Age and region-specific responses of microglia, but not astrocytes, suggest a role in selective vulnerability of dopamine neurons after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure in monkeys. Glia 56:1199–1214
Kieburtz KD, Epstein LG, Gelbard HA, Greenamyre JT (1991) Excitotoxicity and dopaminergic dysfunction in the acquired immunodeficiency syndrome dementia complex. Therapeutic implications. Arch Neurol 48:1281–1284
Kim HJ, Shin AH, Thayer SA (2011) Activation of cannabinoid type 2 receptors inhibits HIV-1 envelope glycoprotein gp 120-induced synapse loss. Mol Pharmacol 80:357–366
Kumar AM, Fernandez JB, Singer EJ, Commins D, Waldrop-Valverde D, Ownby RL, Kumar M (2009) Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains. J Neuro-Oncol 15:257–274
Lashomb AL, Vigorito M, Chang SL (2009) Further characterization of the spatial learning deficit in the human immunodeficiency virus-1 transgenic rat. J Neuro-Oncol 15:14–24
Lassiter C, Fan X, Joshi PC, Jacob BA, Sutliff RL, Jones DP, Koval M, Guidot DM (2009) HIV-1 transgene expression in rats causes oxidant stress and alveolar epithelial barrier dysfunction. AIDS ResTher 6(1). https://doi.org/10.1186/1742-6405-6-1
Lee DE, Yue X, Ibrahim WG, Lentz MR, Peterson KL, Jagoda EM, Kassiou M, Maric D, Reid WC, Hammoud DA (2015) Lack of neuroinflammation in the HIV-1 transgenic rat: an [18F]-DPA714 PET imaging study. J Neuroinflammation 12:171. https://doi.org/10.1186/s12974-015-0390-9
Letendre SL, Ellis RJ, Ances BM, McCutchan JA (2010) Neurologic complications of HIV disease and their treatment. Top HIV Med 18:45–55
Levine AJ, Soontornniyomkij V, Achim CL, Masliah E, Gelman BB, Sinsheimer JS, Singer EJ, Moore DJ (2016) Multilevel analysis of neuropathogenesis of neurocognitive impairment in HIV. J Neuro-Oncol 22:431–441
Leibrand CR, Paris JJ, Ghandour MS, Knapp PE, Kim WK, Hauser KF, McRae M (2017) HIV-1 Tat disrupts blood-brain barrier integrity and increases phagocytic perivascular macrophages and microglia in the dorsal striatum of transgenic mice. Neurosci Lett 640:136–143
Li MD, Cao J, Wang S, Wang J, Sarkar S, Vigorito M, Ma JZ, Chang SL (2013) Transcriptome sequencing of gene expression in the brain of the HIV-1 transgenic rat. PLoS One. https://doi.org/10.1371/journal.pone.0059582
Liu X, Chang L, Vigorito M, Kass M, Li H, Chang SL (2009) Methamphetamine-induced behavioral sensitization is enhanced in the HIV-1 transgenic rat. J NeuroImmune Pharmacol 4(3):309–316
Lopez OL, Smith G, Meltzer CC, Becker JT (1999) Dopamine systems in human immunodeficiency virus-associated dementia. Neuropsychiatry Neuropsychol Behav Neurol 12:184–192
Mamik MK, Hui E, Branton WG, McKenzie BA, Chisholm J, Cohen EA, Power C (2017) HIV-1 viral protein R activates NLRP3 inflammasome in microglia: implications for HIV-1 associated neuroinflammation. J NeuroImmune Pharmacol 12:233–248
Marcario JK, Manaye KF, Santacruz KS, Mouton PR, Berman NEJ, Cheney PD (2004) Severe subcortical degeneration in macaques infected with neurovirulent simian immunodeficiency virus. J Neurovirol 10:1–13
Marker DF, Tremblay M-E, Puccini JM, Barbieri J, Gantz-Maarker MA, Loweth CJ, Muly C, Lu S-M, Goodfellow VS, Dewhurst S, Gelbard HA (2013) The new small-molecule mixed-lineage kinase 3 inhibitor URMC-099 is neuroprotective and anti-inflammatory in models of human immunodeficiency virus-associated neurocognitive disorders. J Neurosci 33:9998–10010
Massaquoi SG, Hallett M (1998) Ataxia and other cerebellar syndromes. In: Jankovic J, Tolosa E (eds) Parkinson’s disease and movement disorders. Williams & Wilkins, Baltimore
McArthur JC, Steiner J, Sacktor N, Nath A (2010) Human immunodeficiency virus-associated neurocognitive disorders: mind the gap. Ann Neurol 67:699–714
McIntosh S, Sexton T, Pattison LP, Childers SR, Hemby SE (2015) Increased sensitivity to cocaine self-administration in HIV-1 transgenic rats is associated with changes in striatal dopamine transporter binding. J NeuroImmune Pharmacol 10:493–505
McLaurin KA, Booze RM, Mactutus CF, Fairchild AJ (2017) Sex matters: robust sex differences in signal detection in the HIV-1 transgenic rat. Front Behav Neurosci 11:212. https://doi.org/10.3389/fnbeh.2017.00212
McLaurin KA, Booze RM, Mactutus CF (2018) Evolution of the HIV-1 transgenic rat: utility in assessing the progression of HIV-1 associated neurocognitive disorders. J Neurovirol 24:229–245
Miller DR, Shaerzadeh F, Phan L, Sharif, Gamble-George J, McLaughlin JP, Streit WJ, Khoshbouei H (2018) HIV-1 Tat regulation of dopamine transmission and microglial reactivity is brain region specific. Glia. https://doi.org/10.1002/glia.23447
Moran LM, Booze RM, Webb KM, Mactutus CF (2013) Neurobehavioral alterations in HIV-1 transgenic rats: evidence for dopaminergic dysfunction. Exp Neurol 239:139–147
Moscarello JM, LeDoux JE (2013) Active avoidance learning requires prefrontal suppression of amygdala-mediated defensive reactions. J Neurosci 33:3815–3823
Mouton PR, Gokhale AM, Ward NL, West MJ (2002) Stereological length estimation using spherical probes. J Microsc 206(1):54-64
Mouton PR, Gordon M (2010) Stereological and image analysis techniques for quantitative assessment of neurotoxicology. In: Neurotoxicology, 3rd ed. Ed: GJ Harry, H.A. Tilson, London: Informa Press
Nemeth CL, Glasper ER, Harrell CS, Malviya SA, Otis JS, Neigh GN (2014) Meloxicam blocks neuroinflammation, but not depressive-like behaviors, in HIV-1 transgenic female rats. PLoS One 9(10):e108399
Nesil T, Cao J, Yang Z, Chang SL, Li MD (2015) Nicotine attenuates the effect of HIV-1 proteins on the neural circuits of working and contextual memories. Mol Brain 8:43. https://doi.org/10.1186/s13041-015-0134-x
Nolan RA, Muir R, Runner K, Haddad EK, Gaskill PJ (2019) Pole of macrophage dopamine receptors in mediating cytokine production: implications for neuroinflammation in the context of HIV-associated neurocognitive disorders. J NeuroImmune Pharmacol 14:134–156
Nosheny RL, Bachis A, Aden SA, DeBernardi MA, Mocchetti I (2006) Intrastriatal administration of human immunodeficiency virus-1 glycoprotein 120 reduces glial cell-line derived neurotrophic factor levels and causes apoptosis in the substantia nigra. J Neurobiol 66:1311–1321
NTP (National Toxicology Program) (2015) Neurobehavioral testing specifications. https://ntp.niehs.nih.gov/ntp/test_info/finalntp_ neurospecs090415_508.pdf [accessed 06/14/2019]
Packard MG, White NM (1991) Dissociation of hippocampus and caudate nucleus memory systems by posttraining intracerebral injection of dopamine agonists. Behav Neurosci 105:295–306
Pang X, Panee J (2016) Anti-inflammatory function of Phyllostachys edulis extract in the hippocampus of HIV-1 transgenic mice. J HIV AIDS 2(3). https://doi.org/10.16966/2380-5536.126
Peng J, Vigorito M, Liu X, Zhou D, Wu X, Chang SL (2010) The HIV-1 transgenic rat as a model for HIV-1 infected individuals on HAART. J Neuroimmunol 218:94–101
Ramirez F, Moscarello JM, LeDoux JE, Sears RM (2015) Active avoidance requires a serial basal amygdala to nucleus accumbens shell circuit. J Neurosci 35:3470–3477
Rao VR, Ruiz AP, Prasad VR (2014) Viral and cellular factors underlying neuropathogenesis in HIV associated neurocognitive disorders (HAND). AIDS Res Ther. https://doi.org/10.1186/1742-6405-11-13
Rappert A, Bechmann I, Pivneva T, Mahlo J, Biber K, Nolte C, Kovac AD, Gerard C, Boddeke HW, Nitsch R, Kettenmann H (2004) CXCR3-dependent microglial recruitment is essential for dendrite loss after brain lesion. J Neurosci 24:8500–8509
Ravichandran KS (2003) “Recruitment signals” from apoptotic cells: invitation to a quiet meal. Cell 113(7):817–820
Reid WC, Ibrahim WG, Kim SJ, Denaro F, Casas R, Lee DE, Maric D, Hammoud DA (2016a) Characterization of neuropathology in the HIV-1 transgenic rat at different ages. J Neuroimmunol 292:116–125
Reid WC, Casas R, Papadakis GZ, Muthusamy S, Lee DE, Ibrahim WG, Nair A, Koziol D, Maric D, Hammoud DA (2016b) Neurobehavioral abnormalities in the HIV-1 transgenic rat do not correspond to neuronal hypometabolism on 18F-FDG-PET. PLoS One 11(3):e0152265. https://doi.org/10.1371/journal.pone.0152265
Reid W, Sadowska M, Denaro F, Rao S, Foulke J Jr, Hayes N, Jones O, Doodnauth D, Davis H, Sill A, O'Driscoll P, Huso D, Fouts T, Lewis G, Hill M, Kamin-Lewis R, Wei C, Ray P, Gallo RC, Reitz M, Bryant J (2001) An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. Proc Natl Acad Sci U S A 98(16):9271–9276
Repunte-Canonigo V, Lefebvre C, George O, Kawamura T, Morales M, Koob GF, Califano A, Masliah E, Sanna PP (2014) Gene expression changes consistent with neuroAIDS and impaired working memory in HIV-1 transgenic rats. Mol Neurodegener 9:26. https://doi.org/10.1186/1750-1326-9-26
Reyes MG, Faraldi F, Senseng S, Flowers C, Pariello R (1991) Nigral degeneration in acquired immune deficiency syndrome (AIDS). Acta Neuropathol 82:39–44
Roscoe RF Jr, Mactutus CF, Booze RM (2014) HIV-1 transgenic female rat: synaptodendritic alterations of medium spiny neurons in the nucleus accumbens. J NeuroImmune Pharmacol 9(5):642–653
Rowson SA, Harrell CS, Bekhbat M, Gangavelli A, Wu MJ, Kelly SD, Reddy R, Neigh GN (2016) Neuroinflammation and behavior in HIV-1 transgenic rats exposed to chronic adolescent stress. Front Psychiatry 7:102. https://doi.org/10.3389/fpsyt.2016.00102
Royal W III, Zhang L, Guo M, Jones O, David H, Bryant JL (2012) Immune activation, viral gene product expression and neurotoxicity in the HIV-1 transgenic rat. J Neuroimmunol 247:16–24
Rozzi SJ, Avdoshina V, Fields JA, Trejo M, Ton HT, Ahem GP, Mocchetti I (2017) Human immunodeficiency virus promotes mitochondrial toxicity. Neurotox Res 32:723–733
Ru W, Tang S-J (2017) HIV-associated synaptic degeneration. Mol Brain 10:40. https://doi.org/10.1186/s13041-017-0321-z
Sacktor N, Robertson K (2014) Evolving clinical phenotypes in HIV-associated neurocognitive disorders. Curr Opin HIV AIDS 9(6):517–520
Sanford R, Fellows LK, Ances BM, Collins DL (2018) Association of brain structure changes and cognitive function with combinational antiretroviral therapy in HIV-positive individuals. JAMA Neurol 75:72–79
Sanna PP, Repunte-Canonigo V, Masliah E, Lefebvre C (2017) Gene expression patterns associated with neurological disease in human HIV infection. PLoS One 12(4):e0175316. https://doi.org/10.1371/journal.pone.0175316
Saylor D, Dickens AM, Sacktor N, Haughey N, Slusher B, Pletnikov M, Mankowski JL, Brown A, Volsky DJ, McArthur JC (2016) HIV-associated neurocognitive disorder-pathogenesis and prospects for treatment. Nat Rev Neurol 12:234–248
Schier CJ, Marks WD, Paris JJ, Barbour AJ, McLane VD, Maragos WF, McQuiston AR, Knapp PE, Hauser KF (2017) Selective vulnerability of striatal D2 versus D1 dopamine receptor-expressing medium spiny neurons in HIV-1 Tat transgenic male mice. J Neurosci 37:5758–5769
Schouten J, Cinque P, Gisslen M, Reiss P, Portegies P (2011) HIV-1 infection and cognitive impairment in the cART era: a review. AIDS 25(5):561–575
Shin AH, Kim HJ, Thayer SA (2012) Subtype selective NMDA receptor antagonists induce recovery of synapses lost following exposure to HIV-1 Tat. Br J Pharmacol 166:1002–1017
Sheppard DP, Woods SP, Bondi MW, Gilbert PE, Massman PJ, Doyle KL, HIV Neurobehavioral Research Program (2015) Does older age confer an increased risk of incident neurocognitive disorders among persons living with HIV disease? Clin Neuropsychol 29:656–677
Silvers JM, Aksenov MY, Aksenova MV, Beckley J, Olton P, Mactutus CF, Booze RM (2006) Dopaminergic marker proteins in the substantia nigra of human immunodeficiency virus type 1-infected brains. J NeuroVirol 12:140–145
Sinharay S, Lee D, Shah S, Muthusamy S, Papadakis GZ, Zhang X, Maric D, Reid WC, Hammoud DA (2017) Cross-sectional and longitudinal small animal PET shows pre and post-synaptic striatal dopaminergic deficits in an animal model of HIV. Nucl Med Biol 55:27–33
Stuchlik A, Rehakova L, Telensky P, Vales K (2007) Morris water maze learning in Long-Evans rats is differentially affected by blockade of D1-like and D2-like dopamine receptors. Neurosci Lett 422:169–174
Theodore S, Cass WA, Dwoskin LP, Maragos WF (2012) HIV-1 protein Tat inhibits vesicular monamine transporter-2 activity in rat striatum. Synapse 66:755–757
Underwood J, Cole JH, Caan M, DeFrancesco D, Leech R, van Zoest RA, Su T, Geurtsen GJ, Schmand BA, Portegies P, Prins M, Wit FW, Sabin CA, Majoie C, Reiss P, Winston A, Sharp DJ (2017) Gray and white matter abnormalities in treated HIV-disease and their relationship to cognitive function. Clin Infect Dis 65:422–432
van den Dries LWJ, Wagener MN, Jiskoot LC, Visser M, Robertson KR, Adriani KS, van Gorp ECM (2017) Neurocognitive impairment in a chronically well-suppressed HIV-infected population: the Dutch TREVI cohort study. AIDS Patient Care STDs 31:329–334
Vera JH, Guo Q, Cole JH, Boasso A, Greathead L, Kelleher P, Rabiner EA, Kalk N, Bishop C, Gunn RN, Matthews PM, Winston A (2016) Neuroinflammation in treated HIV-positive individuals: a TSPO PET study. Neurology 86:1425–1432
Vigorito M, Lashomb AL, Chang SL (2007) Spatial learning and memory in HIV-1 transgenic rats. J NeuroImmune Pharmacol 2:319–328
Vigorito M, Cao J, Li MD, Chang SL (2013) Acquisition and long-term retention of spatial learning in the human immunodeficiency virus-1 transgenic rat: effects of repeated nicotine treatment. J Neuro-Oncol 19:157–165
Walsh JG, Reinke SN, Mamik MK, McKenzie BA, Maingat F, Branton WG, Broadhurst DI, Power C (2014) Rapid inflammasome activation in microglia contributes to brain disease in HIV/AIDS. Retrovirology 11:35. https://doi.org/10.1186/1742-4690-11-35
Wang GJ, Chang L, Volkow ND, Telang F, Logan J, Ernst T, Fowler JS (2004) Decreased brain dopaminergic transporters in HIV-associated dementia patients. Brain 127:2452–2458
Webb KM, Aksenov MY, Mactutus CF, Booze RM (2010) Evidence for developmental dopaminergic alterations in the human immunodeficiency virus-1 transgenic rat. J Neurovirol 16:168–173
Yadav A, Collman RG (2009) CNS inflammation and macrophage/microglial biology associated with HIV-1 infection. J NeuroImmune Pharmacol 4:430–447
Yang Z, Nesil T, Connaghan KP, Li MD, Chang S (2016) Modulation effect of HIV-1 viral proteins and nicotine on expression of the immune-related genes in brain of the HIV-1 transgenic rats. J NeuroImmune Pharmacol 11:562–571
Zayyad Z, Spudich S (2015) Neuropathogenesis of HIV: from initial neuroinvasion to HIV-associated neurocognitive disorder (HAND). Curr HIV/AIDS Rep 12:16–24
Zhu J, Yuan Y, Midde NM, Gomez AM, Sun WL, Quizon PM, Zhan CG (2016) HIV-1 transgenic rats display and increase in 3[H] dopamine uptake in the prefrontal cortex and striatum. J Neurovirol 22:282–292
Funding
This work was supported in part by HHS grants NS079172 and NS074916 to IM and NIH intramural research funding Z01 ES021164-12 and Z01 ES101623-05 to JH.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Animal studies were done in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals following approved animal protocols from the Animal Care and Use Committee of the National Institute of Environmental Health Sciences.
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic Supplementary Material
ESM 1
(PDF 6097 kb)
Rights and permissions
About this article
Cite this article
Goulding, D., Kraft, A., Mouton, P.R. et al. Age-Related Decrease in Tyrosine Hydroxylase Immunoreactivity in the Substantia Nigra and Region-Specific Changes in Microglia Morphology in HIV-1 Tg Rats. Neurotox Res 36, 563–582 (2019). https://doi.org/10.1007/s12640-019-00077-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12640-019-00077-z